# Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1

> **NCT01956110** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 1329 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Follitropin Delta (FE 999049)
- **DRUG:** Follitropin Alfa (GONAL-F)

## Key facts

- **NCT ID:** NCT01956110
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-05
- **Final completion:** 2017-01-03
- **Target enrollment:** 1329 (ACTUAL)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956110, "Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01956110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*